Neptune Technologies & Bioresources Inc. announced the filing of a complaint in the United States International Trade Commission against multiple infringers, including Aker BioMarine ASA, for infringement of U.S. Patent No. 8,278,351, which contains composition of matter claims. Aker, in a clear attempt to shift the focus from the ITC action, has issued a press release addressing the re-examination of a different Neptune patent that is directed to methods of use.
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
96 NOK | +2.56% |
|
+3.23% | +108.70% |
07-12 | Aker BioMarine AS Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024 | CI |
07-12 | Aker BioMarine AS Expects to Pay Extraordinary Dividend | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+108.70% | 758M | |
+1.60% | 18.67B | |
+16.64% | 3.47B | |
+53.53% | 1.97B | |
+2.82% | 1.57B | |
-.--% | 1.27B | |
-12.02% | 1.23B | |
+8.06% | 1.26B | |
+6.33% | 1.19B | |
0.00% | 1.19B |
- Stock Market
- Equities
- AKBM Stock
- News Aker BioMarine
- Neptune Technologies & Bioresources, Inc. Files Complaint against Multiple Infringers, Including Aker BioMarine ASA for Infringement of U.S. Patent No. 8,278,351